Publicaciones
-
Luciano JV, Carlos Garcia Forero, Marta Cerdà Lafont, Peñarrubia-María MT, Fernández-Vergel R, JOSE MIGUEL RUIZ MARTIN, Rozadilla A, Sirvent Alierta, Elena, Santo Panero, Pilar, García Campayo, Javier, Serrano-Blanco A and Rubio-Valera M.
Functional Status, Quality of Life, and Costs Associated With Fibromyalgia Subgroups: A Latent Profile Analysis.
CLINICAL JOURNAL OF PAIN . 32(10): 829-840. Nº de citas: 33
-
Gumà-Uriel L, Peñarrubia-María MT, Cerdà-Lafont M, Cunillera-Puertolas O, Almeda-Ortega J, Fernández-Vergel R, García-Campayo J and Luciano JV.
Impact of IPDE-SQ personality disorders on the healthcare and societal costs of fibromyalgia patients: a cross-sectional study.
BMC FAMILY PRACTICE . 17(1): 61-61. Nº de citas: 9
-
Rubio-Valera M, Peñarrubia-María MT, Fernández-Vergel R, Carvajal Tejadillo AC, Fernández A, Aznar-Lou I, March-Pujol M and Serrano-Blanco A.
Impact of pharmaceutical intervention in preventing relapses in depression in Primary Care
ATENCION PRIMARIA . 48(5): 308-315. Nº de citas: 4
-
Rubio-Valera M, Beneitez I, Peñarrubia-María MT, Luciano JV, Mendive JM, McCrone P, Knapp M, Sabés-Figuera R, Katarzyna Kocyan, García-Campayo J and Serrano-Blanco A.
Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study).
BMC Psychiatry . 15(1): 63-63. Nº de citas: 10
-
Luciano JV, D Amico F, Cerdà-Lafont M, Peñarrubia-María MT, Knapp M, Cuesta-Vargas AI, Serrano-Blanco A and García-Campayo J.
Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial.
ARTHRITIS RESEARCH & THERAPY . 16(5): 451-451. Nº de citas: 37
-
Rubio-Valera M, March Pujol M, Fernández A, Peñarrubia-María MT, Travé P, López Del Hoyo Y and Serrano-Blanco A.
Evaluation of a pharmacist intervention on patients initiating pharmacological treatment for depression: A randomized controlled superiority trial
EUROPEAN NEUROPSYCHOPHARMACOLOGY . 23(9): 1057-1066. Nº de citas: 45
-
Cuesta-Vargas A, Luciano JV, Peñarrubia-María MT, García-Campayo J, Fernández-Vergel R, Arroyo-Morales M and Serrano-Blanco A.
Clinical dimensions of fibromyalgia symptoms and development of a combined index of severity: the CODI index.
QUALITY OF LIFE RESEARCH . 22(1): 153-160. Nº de citas: 5
-
Luciano JV, Sabes R, Cardeñosa E, Peñarrubia-María MT, Fernández-Vergel R, Garcia-Campayo, Javier, Martin Knapp and Serrano-Blanco A.
Cost-Utility of a Psychoeducational Intervention in Fibromyalgia Patients Compared With Usual Care An Economic Evaluation Alongside a 12-Month Randomized Controlled Trial
CLINICAL JOURNAL OF PAIN . 29(8): 702-711. Nº de citas: 46
-
Luciano JV, Martínez N, Peñarrubia-María MT, Fernández-Vergel R, García-Campayo J, Verduras C, Blanco ME, Jiménez M, Ruiz JM, López del Hoyo Y and Serrano-Blanco A.
Effectiveness of a psychoeducational treatment program implemented in general practice for fibromyalgia patients: a randomized controlled trial.
CLINICAL JOURNAL OF PAIN . 27(5): 383-391. Nº de citas: 44
-
Fernández A, Pinto-Meza A, Bellón JA, Roura-Poch P, Haro JM, Autonell J, Palao DJ, Peñarrubia-María MT, Fernández R, Blanco E, Luciano JV and Serrano-Blanco A.
Is major depression adequately diagnosed and treated by general practitioners? Results from an epidemiological study.
GENERAL HOSPITAL PSYCHIATRY . 32(2): 201-209. Nº de citas: 79